This course delivers a detailed breakdown of the FDA’s rule classifying ingestible gastrointestinal blood detection capsules as class II devices with special controls. Learn how to fulfill compliance requirements, meet regulatory standards for clinical and non-clinical testing, execute proper labeling for both physicians and patients, and avoid penalties. The training is vital for ensuring device safety, effective market entry, and long-term regulatory success.
In this course you will learn the following:
* Understand the FDA’s classification process for new medical devices, specifically the De Novo pathway.
* Identify the special controls and general controls applicable to ingestible gastrointestinal blood detection capsules.
* Implement the required testing, labeling, and documentation to ensure compliance.
* Recognize the legal and regulatory consequences of failing to comply with the final rule.
